AbbVie
ABBV
$237.02
Share price
2.07%
Change (1 day)
2.76%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
Market capitalization of AbbVie (ABBV)
Market cap: S$419.28 Billion
As of April 2025 AbbVie has a market cap of S$419.28 Billion. This makes AbbVie the world's 28th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of AbbVie from 2012 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | S$419.28 B | -1.94% |
| 2024 | S$427.58 B | 18.33% |
| 2023 | S$361.35 B | -5.69% |
| 2022 | S$383.14 B | 18.4% |
| 2021 | S$323.60 B | 29.31% |
| 2020 | S$250.26 B | 41.76% |
| 2019 | S$176.53 B | -5.22% |
| 2018 | S$186.25 B | -9.8% |
| 2017 | S$206.49 B | 40.21% |
| 2016 | S$147.28 B | 9.18% |
| 2015 | S$134.90 B | -1.96% |
| 2014 | S$137.60 B | 29.56% |
| 2013 | S$106.20 B | 60.91% |
| 2012 | S$66.00 B |
End of Day market cap according to different sources
On Apr 23rd, 2025 the market cap of AbbVie was reported to be:
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 | S$169.93 B | -59.47% | 🇺🇸 USA |
 | S$129.91 B | -69.01% | 🇺🇸 USA |
 | S$1.006 T | 139.97% | 🇺🇸 USA |
 | S$197.25 B | -52.95% | 🇺🇸 USA |
 | S$174.25 B | -58.44% | 🇺🇸 USA |
 | S$22.96 B | -94.52% | 🇺🇸 USA |
 | S$99.34 B | -76.31% | 🇬🇧 UK |
 | S$282.33 B | -32.66% | 🇬🇧 UK |
 | S$13.58 B | -96.76% | 🇺🇸 USA |